Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation - PubMed (original) (raw)
Affiliations
- PMID: 14757847
Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation
Daniel J Weisenberger et al. Mol Cancer Res. 2004 Jan.
Abstract
Several alternatively spliced variants of DNA methyltransferase (DNMT) 3b have been described. Here, we identified new murine Dnmt3b mRNA isoforms and found that mouse embryonic stem (ES) cells expressed only Dnmt3b transcripts that contained exons 10 and 11, whereas the Dnmt3b transcripts in somatic cells lacked these exons, suggesting that this region is important for embryonic development. DNMT3b2 and 3b3 were the major isoforms expressed in human cell lines and the mRNA levels of these isoforms closely correlated with their protein levels. Although DNMT3b3 may be catalytically inactive, it still may be biologically important because D4Z4 and satellites 2 and 3 repeat sequences, all known DNMT3b target sequences, were methylated in cells that predominantly expressed DNMT3b3. Treatment of cells with the mechanism-based inhibitor 5-aza-2'-deoxycytidine (5-Aza-CdR) caused a complete depletion of DNMT1, 3a, 3b1, and 3b2 proteins. Human DNMT3b3 and the murine Dnmt3b3-like isoform, Dnmt3b6, were also depleted although less efficiently, suggesting that DNMT3b3 also may be capable of DNA binding. Moreover, de novo methylation of D4Z4 in T24 cancer cells after 5-Aza-CdR treatment only occurred when DNMT3b3 was expressed, reinforcing its role as a contributing factor of DNA methylation. The expression of either DNMT3b2 or 3b3, however, was not sufficient to explain the abnormal methylation of DNMT3b target sequences in human cancers, which may therefore be dependent on factors that affect DNMT3b targeting. Methylation analyses of immunodeficiency, chromosomal instabilities, and facial abnormalities cells revealed that an Alu repeat sequence was highly methylated, suggesting that Alu sequences are not DNMT3b targets.
Similar articles
- De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2'-deoxycytidine.
Oka M, Meacham AM, Hamazaki T, Rodić N, Chang LJ, Terada N. Oka M, et al. Oncogene. 2005 Apr 28;24(19):3091-9. doi: 10.1038/sj.onc.1208540. Oncogene. 2005. PMID: 15735669 - Preference of DNA methyltransferases for CpG islands in mouse embryonic stem cells.
Hattori N, Abe T, Hattori N, Suzuki M, Matsuyama T, Yoshida S, Li E, Shiota K. Hattori N, et al. Genome Res. 2004 Sep;14(9):1733-40. doi: 10.1101/gr.2431504. Epub 2004 Aug 12. Genome Res. 2004. PMID: 15310660 Free PMC article. - The inactive Dnmt3b3 isoform preferentially enhances Dnmt3b-mediated DNA methylation.
Zeng Y, Ren R, Kaur G, Hardikar S, Ying Z, Babcock L, Gupta E, Zhang X, Chen T, Cheng X. Zeng Y, et al. Genes Dev. 2020 Nov 1;34(21-22):1546-1558. doi: 10.1101/gad.341925.120. Epub 2020 Oct 1. Genes Dev. 2020. PMID: 33004415 Free PMC article. - DNMT3B Functions: Novel Insights From Human Disease.
Gagliardi M, Strazzullo M, Matarazzo MR. Gagliardi M, et al. Front Cell Dev Biol. 2018 Oct 22;6:140. doi: 10.3389/fcell.2018.00140. eCollection 2018. Front Cell Dev Biol. 2018. PMID: 30406101 Free PMC article. Review. - DNA methylation and drug resistance in variants of C3H10T1/2 C1 8 cells.
Michalowsky LA, Jones PA. Michalowsky LA, et al. Prog Clin Biol Res. 1986;226:391-9. Prog Clin Biol Res. 1986. PMID: 2433698 Review. No abstract available.
Cited by
- DNA methyltransferase DNMT3b protein overexpression as a prognostic factor in patients with diffuse large B-cell lymphomas.
Amara K, Ziadi S, Hachana M, Soltani N, Korbi S, Trimeche M. Amara K, et al. Cancer Sci. 2010 Jul;101(7):1722-30. doi: 10.1111/j.1349-7006.2010.01569.x. Epub 2010 Mar 19. Cancer Sci. 2010. PMID: 20398054 Free PMC article. - Quantitative Analysis of Plasma Cell-Free DNA and Its DNA Integrity and Hypomethylation Status as Biomarkers for Tumor Burden and Disease Progression in Patients with Metastatic Neuroendocrine Neoplasias.
Mettler E, Fottner C, Bakhshandeh N, Trenkler A, Kuchen R, Weber MM. Mettler E, et al. Cancers (Basel). 2022 Feb 17;14(4):1025. doi: 10.3390/cancers14041025. Cancers (Basel). 2022. PMID: 35205773 Free PMC article. - Nucleoside drugs induce cellular differentiation by caspase-dependent degradation of stem cell factors.
Musch T, Oz Y, Lyko F, Breiling A. Musch T, et al. PLoS One. 2010 May 19;5(5):e10726. doi: 10.1371/journal.pone.0010726. PLoS One. 2010. PMID: 20502711 Free PMC article. - DNMT3B 579 G>T promoter polymorphism and risk of esophagus carcinoma in Chinese.
Fan H, Liu DS, Zhang SH, Hu JB, Zhang F, Zhao ZJ. Fan H, et al. World J Gastroenterol. 2008 Apr 14;14(14):2230-4. doi: 10.3748/wjg.14.2230. World J Gastroenterol. 2008. PMID: 18407600 Free PMC article. - Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA.
Jeong S, Liang G, Sharma S, Lin JC, Choi SH, Han H, Yoo CB, Egger G, Yang AS, Jones PA. Jeong S, et al. Mol Cell Biol. 2009 Oct;29(19):5366-76. doi: 10.1128/MCB.00484-09. Epub 2009 Jul 20. Mol Cell Biol. 2009. PMID: 19620278 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials